New balloon and laser combo may save legs and money
NCT ID NCT02599389
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested three ways to treat leg arteries that have reblocked after stent placement: standard balloon angioplasty, a drug-coated balloon, and a laser plus drug-coated balloon. The goal was to see which approach is most cost-effective over 18 months. The trial involved 222 adults with symptoms like leg pain or poor circulation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
drug-coated balloon (paclitaxel) and excimer laser
What this could lead to
If successful, this could identify a more cost-effective way to treat reblocked stents in leg arteries, potentially improving blood flow and reducing the need for repeat procedures.
What could go wrong
This is a completed phase 3 trial, but the results may not apply to all patients. The treatments carry risks like vessel damage or recurrence of blockage, and the cost benefits may vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANGIOPLASTY, BALLOON are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Universitaire de Besançon
Besançon, 25030, France
-
Centre Hospitalier Universitaire de Clermont-Ferrand
Clermont-Ferrand, 63000, France
-
Centre Hospitalier Universitaire de Dijon
Dijon, 21079, France
-
Centre Hospitalier Universitaire de Nantes
Nantes, 44093, France
-
Centre Hospitalier Universitaire de St Etienne
Saint-Etienne, 42055, France
-
Centre Hospitalier Universitaire de Strasbourg
Strasbourg, 67091, France
-
Clinique Pasteur
Toulouse, 31076, France
-
Clinique Rhône Durance
Avignon, 84000, France
-
Clinique de L'Europe
Rouen, 76100, France
-
Hospices Civils de Lyon
Lyon, 69000, France
-
Hôpital Européen Georges Pompidou - AP-HP de Paris
Paris, 75015, France
-
Polyclinique Les Fleurs
Ollioules, 83190, France
-
University Hospital of Bordeaux - Hospital Pellegrin
Bordeaux, 33000, France